Genetic testing allows doctors to select best treatment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment
Experimental Hematology & Oncology Open Access 03 November 2021
-
Estimating heterogeneous treatment effect by balancing heterogeneity and fitness
BMC Bioinformatics Open Access 31 December 2018
-
Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine
Journal of Clinical Bioinformatics Open Access 26 March 2015
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Check Hayden, E. Nature 455, 148 (2008).
Mellinghoff, I. K. et al. N. Engl. J. Med. 353, 2012 (2005).
Ley, T. J. et al. Nature 456, 66–72 (2008).
Related links
Rights and permissions
About this article
Cite this article
Hayden, E. Personalized cancer therapy gets closer. Nature 458, 131–132 (2009). https://doi.org/10.1038/458131a
Published:
Issue Date:
DOI: https://doi.org/10.1038/458131a
This article is cited by
-
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment
Experimental Hematology & Oncology (2021)
-
Estimating heterogeneous treatment effect by balancing heterogeneity and fitness
BMC Bioinformatics (2018)
-
Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine
Journal of Clinical Bioinformatics (2015)
